Atorvastatin intra-subject Variability [Study As­sess­ment]

posted by Helmut Homepage – Vienna, Austria, 2017-09-27 11:05  – Posting: # 17833
Views: 3,072

Hi ElMaestro & nobody,

» » Chance?
» Maybe, but...

Quick calculations based on published CV (~35%), full replicate designs (n 40–64): Very, very unlikely; p <10–16.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,487 posts in 4,135 threads, 1,336 registered users;
online 10 (0 registered, 10 guests [including 9 identified bots]).
Forum time (Europe/Vienna): 19:13 CEST

If debugging is the process of removing bugs,
then programming must be the process of putting them in.    Edsger W. Dijkstra

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5